Volume 18, Issue 24
Heterocyclic Compounds
Full Access

ChemInform Abstract: Synthesis, Cell Growth Inhibition, and Antitumor Screening of 2-(p-nButylanilino)purines and Their Nucleoside Analogues.

G. E. WRIGHT

G. E. WRIGHT

Dep. Pharm., Univ. Massachusetts Med. School, Worcester, MA 01605, USA

Search for more papers by this author
L. W. DUDYCZ

L. W. DUDYCZ

Dep. Pharm., Univ. Massachusetts Med. School, Worcester, MA 01605, USA

Search for more papers by this author
Z. KAZIMIERCZUK

Z. KAZIMIERCZUK

Dep. Pharm., Univ. Massachusetts Med. School, Worcester, MA 01605, USA

Search for more papers by this author
N. C. BROWN

N. C. BROWN

Dep. Pharm., Univ. Massachusetts Med. School, Worcester, MA 01605, USA

Search for more papers by this author
N. N. KHAN

N. N. KHAN

Dep. Pharm., Univ. Massachusetts Med. School, Worcester, MA 01605, USA

Search for more papers by this author
First published: June 16, 1987

Abstract

The anilinopurines (II) and their deoxyribofuranosyl derivatives (IV) and (V) are synthesized as outlined in the reaction scheme.

ChemInform Abstract

The anilinopurines (II) and their deoxyribofuranosyl derivatives (IV) and (V) are synthesized as outlined in the reaction scheme. Moreover, the p-butylanilinochloropurine (IIa) is transformed into the hydroxyethoxymethyl derivatives (VI) and (VII). The compounds synthesized are evaluated as inhibitors of DNA polymerase α and tested for antitumor activity in vivo against P388 leukemia. Their effects on cell growth and on macromolecular synthesis are also studied. (UV-, 1H-NMR-data).

    The full text of this article hosted at iucr.org is unavailable due to technical difficulties.